Details of the Drug Formulations

General Information of Drug (ID: DM4EGV0)

Drug Name
Linaclotide Drug Info
Synonyms Linaclotide (USAN)
Indication
Disease Entry ICD 11 Status REF
Irritable bowel syndrome DD91.0 Approved [1]
Cross-matching ID
PubChem CID
16158208
ChEBI ID
CHEBI:68551
CAS Number
851199-59-2
TTD ID
D00GNJ
ACDINA ID
D00366

Full List of Drug Formulations Containing This Drug

Linaclotide 0.072 mg capsule
Company Formulation ID FDA Description
Allergan F12031 Histidine; Talc; Titanium dioxide; Calcium chloride; Cellulose, microcrystalline; Gelatin; Polyvinyl alcohol, unspecified; Powdered cellulose
------------------------------------------------------------------------------------
Linaclotide 0.145 mg capsule
Company Formulation ID FDA Description
Allergan; Avera McKennan Hospital; Lake Eire Medical & Surgical Supply DBA Quality Care Products F12032 Leucine; Titanium dioxide; Calcium chloride; Cellulose, microcrystalline; Gelatin; Hypromelloses
------------------------------------------------------------------------------------
Linaclotide 0.29 mg capsule
Company Formulation ID FDA Description
Allergan F12033 Leucine; Titanium dioxide; Calcium chloride; Cellulose, microcrystalline; Gelatin; Hypromelloses
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5017).